US$ 28.23
vomiting on glp 1 Adverse effects of GLP-1 class drugs. Gastrointestinal issues are GLP-1 Causing Nausea: Navigating Side
Description
Each serving delivers 78 billion CFUs from a broad range of beneficial strains including Lactobacillus, Bifidobacterium, Akkermansia muciniphila and Christensenella minuta, known for their contribution to a balanced gut microbiome

The Phase III trial of this pipeline drug for treating type 2 diabetes mellitus, non-alcoholic fatty liver disease, and obesity started on August 28, 2023
Graphic Abstract

Treatment with GLP1RAs resulted in unaffected or reduced Cmax and delayed tmax of drugs with high solubility and permeability (warfarin, contraceptive pills, acetaminophen), drugs with high solubility and low permeability (angiotensin converting enzyme inhibitors), drugs with low solubility and high permeability (statins) and drugs with low solubility and permeability (digoxin)
As the number of GLP-1 options grew, Novo Nordisk and Lilly invested heavily in promotional campaigns

Although most of the studies reported an association between GLP-1 RA and increased residual gastric contents, evidence linking these medications to a statistically significant rise in regurgitation or aspiration events remains highly inconsistent
